The CFAR Molecular Diversity Core was initiated in 1995 to provide a DNA sequencing service tosupport the AIDS research community. It evolved into the current Genomics Core with a new focus onproviding assistance in assuring HIV sequence quality control and in performing detailed phylogenetic andbioinformatic analyses. Since its inception, the Core has contributed to ten or more collaborative, peerreviewedpublications per year. Going forward, we will continue to develop, refine, implement, support andteach methods for the study of HIV gene sequences. However, we will also broaden the scope of the core inways that together make Computational Biology, rather than Genomics, the most apt description of our newCore.First, we will create an open-source bioinformatics toolkit that includes incorporation of existinganalytical tools together with emerging techniques. This toolkit is being developed in collaboration with thelocal CFAR Biostatistics Core, the Los Alamos National Laboratory (LANL) and investigators at the UCSDCFAR.Second, we will expand our efforts at training and research community outreach. To this end we willdevelop a unified web-based interface to access our analysis tools, using questionnaires to determine needfor tool development and training sessions. We will develop an easier mechanism for users to ask specificquestions or request specific support for both existing tool usage and possibly additional novel analyses.Lastly, we will produce a regular Newsletter to inform the CFAR community of the availability andfunctionality of our computational tools and similar programs from other sources.Third, our CFAR efforts will link and assist parallel and separately funded efforts to develop adatabase to acquire, retain and mine clinical, laboratory and genetic data derived from HIV and infectedhuman hosts. These database and mining tools are being developed, implemented and will be spread toinvestigators throughout the international CFAR community and other AIDS researchers. Development isproceeding through collaboration with all of the major laboratories gathering viral gene sequence data,leaders of those gathering AIDS-related clinical, therapy, host genetics and viral immunology data, as well asthose leading in the area of integrated data analysis. These include investigators at the UW, LANL, sixCFARs that focus on a combination of these areas, as well as the Multicenter AIDS Cohort Study (MACS),the Center for HIV-AIDS Vaccine Immunology (CHAVI), and the Collaborative AIDS Vaccine Discovery(CAVD) and Partners in Prevention (PIP) programs funded by the Bill and Melinda Gates foundation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027757-21
Application #
7479034
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2008-03-01
Project End
2013-02-28
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
21
Fiscal Year
2008
Total Cost
$171,801
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Pyra, Maria; Brown, Elizabeth R; Haberer, Jessica E et al. (2018) Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships. AIDS Behav :
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Edwards, Jessie K; Cole, Stephen R; Moore, Richard D et al. (2018) Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula. Am J Epidemiol :
LaCourse, Sylvia M; Cranmer, Lisa M; Bekker, Adrie et al. (2018) Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database Syst Rev 2018:
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Wagner, Anjuli D; O?Malley, Gabrielle; Firdawsi, Olivia et al. (2018) Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study. J Acquir Immune Defic Syndr 77:393-399
Golovaty, Ilya; Sharma, Monisha; Van Heerden, Alastair et al. (2018) Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr 78:522-526
LaCourse, Sylvia M; Cranmer, Lisa M; Njuguna, Irene N et al. (2018) Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children. Clin Infect Dis 66:1798-1801
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Torres, Thiago S; Harrison, Linda J; La Rosa, Alberto M et al. (2018) Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS 32:583-593

Showing the most recent 10 out of 1275 publications